Summary
The product Testosterone Sustanon 250 mg/ml, submitted by REDMOND PHARMACY, underwent qualitative and quantitative analysis. The batch information provided is LOT: 20SEMRAF, and the total concentration of testosterone esters detected was 280.79 mg/ml.
The analysis was conducted on 7 October 2024, following the sample receipt on 3 October 2024.
Detailed Report
Product Information
- Manufacturer: REDMOND PHARMACY
- Product Name: Testosterone Sustanon 250 mg/ml
- Active Ingredient: Testosterone Propionate: 33.14 mg/ml
- Testosterone Phenylpropionate: 66.50 mg/ml
- Testosterone Isocaproate: 68.23 mg/ml
- Testosterone Decanoate: 112.91 mg/ml
- Testosterone Isocaproate: 68.23 mg/ml
- Testosterone Phenylpropionate: 66.50 mg/ml
- Batch Number: Lot 20SEMRAF
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Processing and Analysis
- Task Number: #50045
- Testing Ordered: 27 September 2024
- Sample Received: 3 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Optitropin.EU (Reseller)
- Analysis Paid For By: Optitropin.EU
Testing Results
- Total Testosterone Ester Concentration: 280.79 mg/ml
Breakdown of Testosterone Esters Detected:
- Testosterone Propionate: 33.14 mg/ml
- Testosterone Phenylpropionate: 66.50 mg/ml
- Testosterone Isocaproate: 68.23 mg/ml
- Testosterone Decanoate: 112.91 mg/ml
Verification Details
- Verification URL: https://janoshik.com/tests/50045_6B23GPEAJXW3
Evaluation and Insights
The detected total concentration of 280.79 mg/ml exceeds the expected 250 mg/ml dosage for Sustanon formulations. The individual ester breakdown appears consistent but shows a slightly higher concentration overall.
Conclusion
This report verifies the presence and appropriate composition of testosterone esters, albeit with a slightly higher-than-expected dosage.
Disclaimer
This report is provided for educational and harm reduction purposes. Product submissions may involve inherent biases, and independent verification is recommended for critical evaluations.
